Gustave Roussy shared on X:
“Gustave Roussy at ESMO26.
Anoitne Hollebecque rapid oral – Safety and efficacy of INCB161734, a novel oral KRAS G12D inhibitor, in combination with chemotherapy in patients (pts) with advanced/metastatic pancreatic ductal adenocarcinoma (PDAC).
2 rapid oral sessions by Pamela Abdayem about prevention, early detection and intervention : – Second primary lung cancer risk in childhood cancer survivors from the FCCSS cohort:
Risk-adapted screening guidelines – Lung cancer prevention in patients with severe mental illness:
A real-world cohort experience from the INTERCEPTION-lung precision prevention program.”
You can also read:
